Companies / Erasca, Inc.

Erasca, Inc.

Nasdaq: ERASCIK 1761918SAN DIEGO, CA

Financials

Revenue—
Net income$-124.55M
Total debt—
Cash$42.54M
Diluted EPS$-0.44
Shares outstanding349.8M

Ownership

349.8M shares outstanding · as of Aug 4, 2026
0.08%Insiders
Ownership
Insiders0.08%279,980
10%+ / strategic4.61%16,111,414
Institutions65.61%229,485,600
Public float29.70%103,885,041

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Chacko David M.CFO and CBO
0.08%279,980
Garner EbunFormerChief Legal Officer
<0.01%25,076
Morris ShannonChief Medical Officer
0.00%0
Bristol James ArthurFormerDirector
——
Casdin Alexander W.Director
——
Lim Jonathan ECEOChairman & CEO · Director · 10% owner
——
Liu Jean IDirector
——
Multani Pratik SDirector
——
Start Valerie Denise HardingFormerDirector
——
Varney Michael DavidFormerDirector
——

Institutional holders 167

View all →
HolderValue% of shares
BlackRock, Inc.$387.54M6.05%
State Street Corporation$223.22M3.48%
ARCH Venture Management, LLC$114.74M2.03%
Geode Capital Management, LLC$97.04M1.71%
Frazier Life Sciences Management, L.P.$84.55M6.50%
Balyasny Asset Management L.P.$83.23M1.47%
VR Adviser, LLC$66.43M5.11%
Janus Henderson Group PLC$59.99M1.06%
Suvretta Capital Management, LLC$53.95M4.15%
Paradigm BioCapital Advisors LP$52.67M4.05%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 1, 2026Garner Ebun
Executive
SellCommon Stock$1.31M-80K
-76.14%
25,076
<0.01% of shares
medium
Jan 7, 2026Garner Ebun
Executive
SellCommon Stock$670.8K-120K
-82.72%
25,076
<0.01% of shares
medium
Mar 4, 2026Morris Shannon
Executive
SellCommon Stock$300.8K-20K
-100.00%
0
0.00% of shares
medium
Jan 7, 2026Garner Ebun
Executive
ExerciseCommon Stock$204.0K+120K
+478.55%
145,076
0.04% of shares
low
Apr 1, 2026Garner Ebun
Executive
ExerciseCommon Stock$136.0K+80K
+319.03%
105,076
0.03% of shares
low
Mar 4, 2026Morris Shannon
Executive
ExerciseCommon Stock$34.0K+20K
20,000
<0.01% of shares
low
Dec 15, 2025Chacko David M.
Executive
OtherCommon Stock$21.3K+18K
+6.79%
279,980
0.08% of shares
low
Dec 15, 2025Garner Ebun
Executive
GrantCommon Stock$4.7K+4K
+18.43%
25,076
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
T. Rowe Price Investment Management, Inc.Passive13G/A—16,111,414—
Paradigm BioCapital Advisors LPPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ERASCommon StockEquity29479A108BBG00MTSR883